Lund Systemic Sclerosis Research Group
21 – 30 of 73
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Recommendations for the execution and reporting of skin ultrasound in systemic sclerosis : an international collaboration under the WSF skin ultrasound group
(
- Contribution to journal › Scientific review
-
Mark
Dipeptidyl peptidase 4 expression is not associated with an activated fibroblast phenotype in idiopathic pulmonary fibrosis
(
- Contribution to journal › Article
-
Mark
Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent Cohorts
(
- Contribution to journal › Article
- 2021
-
Mark
Longitudinal changes in risk status in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis : The UPSIDE study protocol
(
- Contribution to journal › Article
-
Mark
Underfilling decreases left ventricular function in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival
(
- Contribution to journal › Article
-
Mark
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
(
- Contribution to journal › Article
-
Mark
Incidence and prevalence of systemic sclerosis globally : A comprehensive systematic review and meta-analysis
(
- Contribution to journal › Scientific review